Chemical formula: C₁₂H₁₂N₂O₃ Molecular mass: 232.235 g/mol PubChem compound: 4421
Nalidixic acid is a quinolone antibacterial agent for oral administration. Nalidixic acid and related drugs have been shown to cause arthropathy in juvenile animals of most species tested.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| J01MB02 | Nalidixic acid | J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01M Quinolone antibacterials → J01MB Other quinolones |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| NEGGRAM Oral suspension | FDA, National Drug Code (US) | MPI, US: SPL/Old |
Nalidixic acid is an active ingredient of these brands:
Brazil (BR)South Africa (ZA)Turkey (TR)Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
